Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review.

Shah YB, Shaver AL, Beiriger J, Mehta S, Nikita N, Kelly WK, Freedland SJ, Lu-Yao G. Outcomes Following Abiraterone versus Enzalutamide for Prostate Cancer: A Scoping Review. Cancers (Basel). 2022 Aug 03; 14(15).

View in: PubMed